Maternal hyperoxygenation (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 211 | 左心低形成症候群 | 2 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03136835 (ClinicalTrials.gov) | February 2, 2018 | 28/10/2015 | Maternal Hyperoxygenation in Congenital Heart Disease | Maternal Hyperoxygenation in Congenital Heart Disease | Hypoplastic Left Heart Syndrome | Drug: Maternal Hyperoxygenation | The Hospital for Sick Children | NULL | Recruiting | 18 Years | N/A | Female | 20 | Phase 1;Phase 2 | Canada |
| 2 | NCT03147014 (ClinicalTrials.gov) | January 1, 2016 | 4/5/2017 | Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease | Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease | Hypoplastic Left Heart Syndrome;Aortic Coarctation;Atrial Septal Aneurysm | Biological: Maternal hyperoxygenation | Beijing Anzhen Hospital | NULL | Recruiting | N/A | N/A | Female | 600 | N/A | China |